A
Amr Radwan
Researcher at Regeneron
Publications - 5
Citations - 41
Amr Radwan is an academic researcher from Regeneron. The author has contributed to research in topics: Dupilumab & Nasal polyps. The author has an hindex of 2, co-authored 5 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
Claire Hopkins,Martin Wagenmann,Claus Bachert,Claus Bachert,Claus Bachert,Martin Desrosiers,Joseph K. Han,Peter Hellings,Stella E. Lee,Jerome Msihid,Amr Radwan,Paul Rowe,Nikhil Amin,Yamo Deniz,Benjamin Ortiz,Leda Mannent,Rajesh Rout +16 more
TL;DR: In this paper, dupilumab was used to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with sinus surgery when refractory to medical intervention.
Journal ArticleDOI
Effect of Dupilumab Treatment on Blood Eosinophil Levels in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Eosinophilic Esophagitis (EoE), or Atopic Dermatitis (AD)
Michael E. Wechsler,Amy D. Klion,Pierluigi Paggiaro,Parameswaran Nair,Delphine Staumont-Sallé,Amr Radwan,Robert Johnson,Upender Kapoor,Faisal A. Khokhar,Nadia Daizadeh,Zhen Chen,Elizabeth Laws,Juby A. Jacob-Nara,Leda Mannent,Marcella Ruddy,Paul Rowe,Yamo Deniz +16 more
Journal ArticleDOI
Outcome of 583 Entry Double-Blind Placebo-Controlled Peanut Challenges during Screening for the Palisade Phase 3 Oral Immunotherapy Trial
Brian P. Vickery,Kirsten Beyer,A. Wesley Burks,Thomas B. Casale,Jonathan O'b Hourihane,Stacie M. Jones,Amr Radwan,Andrea Vereda,Daniel C. Adelman +8 more
TL;DR: This data indicates that conventional excisional excision is a best method to treat central giant cell granuloma and this work is likely to be a “once-in-a-lifetime event” for adults and children with Huntington’s disease.
Journal ArticleDOI
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma.
Jonathan Corren,Constance H. Katelaris,Constance H. Katelaris,Mario Castro,Jorge Maspero,Linda B. Ford,David M.G. Halpin,Megan S. Rice,Amr Radwan,Yamo Deniz,Paul Rowe,Ariel Teper,Michel Djandji +12 more
TL;DR: In this paper, the effect of dupilumab on efficacy outcomes and asthma control across a range of historical exacerbation rates in patients with type 2-high asthma was assessed in the phase 3 LIBERTY ASTHMA QUEST study.
Journal ArticleDOI
At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy
Stacie M. Jones,Brian P. Vickery,J. Andrew Bird,Jonathan M. Spergel,Rima Rachid,Amal Assa'ad,Julie Wang,Stephanie A. Leonard,Susan Laubach,Edwin H. Kim,Benjamin P. Davis,MJ Welch,Jennifer Heimall,Antonella Cianferoni,Andrew J. MacGinnitie,Elena Crestani,Amr Radwan,Andrea Vereda,Daniel C. Adelman,A. Wesley Burks +19 more
TL;DR: Overall adherence in the combined analysis of AR101 and PBO was 95% At-Home Dosing Adherence During Characterized Oral Desensitization Immunotherapy for Peanut Allergy.